Experts explain how GLP-1 drugs like Ozempic and Mounjaro work for obesity and weight loss, who should use them, side effects, costs in India, and why they must be treated as medical tools.
What if there was a drug that could treat addiction, reduce your risk of cardiovascular disease and colorectal cancer, mitigate symptoms of polycystic ovary syndrome (PCOS), lower your blood sugar, ...
Ozempic and similar weight loss drugs offer major benefits for obesity and heart health, but side effects, muscle loss, and ...
Zepbound (tirzepatide) and Ozempic (semaglutide) are brand-name subcutaneous injections. They’re both prescribed for weight loss and weight management, but only Zepbound has been FDA-approved for this ...
Popular weight-loss drugs like Ozempic and Wegovy can dramatically curb appetite, but experts warn many users are flying blind when it comes to nutrition. New research suggests people taking these ...
Verywell Health on MSN
Wegovy vs. Ozempic: Which is the better weight loss drug?
Medically reviewed by Femi Aremu, PharmD Key Takeaways While both contain semaglutide, Wegovy is approved specifically for weight management, whereas Ozempic is approved for the treatment of type 2 ...
Add Yahoo as a preferred source to see more of our stories on Google. With more people turning to popular weight-loss medications, questions about potential side effects are increasing — and some ...
Some people may notice weight gain while using Ozempic or after stopping the drug. Reasons for weight gain while using Ozempic may include changes in appetite and reduced physical activity due to side ...
A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have “an antidepressant effect,” suggesting that these drugs could one day ...
MedPage Today on MSN
Potentially blinding eye condition tied to Ozempic again
Absolute risk for nonarteritic anterior ischemic optic neuropathy remained low, however ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results